Atea Pharmaceuticals (AVIR) Receivables (2021 - 2022)
Historic Receivables for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q3 2022 value amounting to $4.5 million.
Historic Receivables for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q3 2022 value amounting to $4.5 million.